Literature DB >> 10330962

Leukocyte response to thymoglobulin or atgam for induction immunosuppression in a randomized, double-blind clinical trial in renal transplant recipients.

D C Brennan1, K Flavin, J A Lowell, T K Howard, S Shenoy, S Burgess, S Dolan, J M Kano, M Mahon, M A Schnitzler, R Woodward, W Irish, V Ramachamdra, G G Singer.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10330962     DOI： 10.1016/s0041-1345(99)00096-2

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  2 in total

Review 1.  Current landscape for T-cell targeting in autoimmunity and transplantation.

Authors:  Daniel R Getts; Sushma Shankar; Emily M L Chastain; Aaron Martin; Meghann Teague Getts; Kathryn Wood; Stephen D Miller
Journal:  Immunotherapy       Date:  2011-07       Impact factor: 4.196

2.  Induction Therapy in Immunologically Well-Matched Recipients: Less May Be More.

Authors:  Vishnu S Potluri; Roy D Bloom
Journal:  Clin J Am Soc Nephrol       Date:  2022-02       Impact factor: 10.614
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.